Agentix (AGTX) Net Equity Issued and Repurchased (2015)

Agentix's (AGTX) quarterly Net Equity Issued and Repurchased came in at $27000.0 in Q2 2015.

Agentix (AGTX) Net Equity Issued and Repurchased (2015) Analysis & Trends

Agentix (AGTX) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $27000.0 in Q2 2015.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $27000.0 in Q2 2015, while the trailing twelve-month figure through Aug 2021 was $27000.0 (changed N/A YoY) and the FY2023 annual result came in at $50000.0, changed N/A from the prior year.
Net Equity Issued and Repurchased was little changed at $27000.0 in Q2 2015.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $27000.0 in Q2 2015 to a low of $27000.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Agentix	801,339.00	801,301.00	-	-

Download Data

Date	Value
May 31, 2015	27,000.00
May 31, 2015	27,000.00